IGF1R and fatty liver disease: In these studies, BCAA supplementation suppressed liver carcinogenesis by reducing insulin resistance, ameliorating hepatic steatosis, inhibiting activation of the IGF/IGF-1R axis, and attenuating hepatic inflammation [34,39].